As of May 23, 2025, Oxford Instruments PLC has a Discounted Cash Flow (DCF) derived fair value of $0.00 per share. With the current market price at $0.00, this represents a potential upside of -28.3%.
Key Metrics | Value |
---|---|
DCF Fair Value (5-year) | $0.00 |
DCF Fair Value (10-year) | $0.00 |
Potential Upside (5-year) | -36.5% |
Potential Upside (10-year) | -28.3% |
Discount Rate (WACC) | 9.8% - 12.3% |
Revenue is projected to grow from $470 million in 03-2024 to $803 million by 03-2034, representing a compound annual growth rate of approximately 5.5%.
Fiscal Year | Revenue (USD millions) | Growth |
---|---|---|
03-2024 | 470 | 6% |
03-2025 | 503 | 7% |
03-2026 | 529 | 5% |
03-2027 | 561 | 6% |
03-2028 | 586 | 4% |
03-2029 | 629 | 7% |
03-2030 | 642 | 2% |
03-2031 | 669 | 4% |
03-2032 | 720 | 8% |
03-2033 | 738 | 2% |
03-2034 | 803 | 9% |
Net profit margin is expected to improve from 11% in 03-2024 to 16% by 03-2034, driven by operational efficiency and economies of scale.
Fiscal Year | Net Profit (USD millions) | Profit Margin |
---|---|---|
03-2024 | 51 | 11% |
03-2025 | 65 | 13% |
03-2026 | 72 | 14% |
03-2027 | 81 | 14% |
03-2028 | 89 | 15% |
03-2029 | 100 | 16% |
03-2030 | 102 | 16% |
03-2031 | 106 | 16% |
03-2032 | 114 | 16% |
03-2033 | 117 | 16% |
03-2034 | 127 | 16% |
with a 5-year average of $18 million. Projected CapEx is expected to maintain at approximately 4% of revenue.
Depreciation is based on an average useful life of 5 years for capital assets.
Fiscal Year | D&A (USD millions) |
---|---|
03-2025 | 20 |
03-2026 | 24 |
03-2027 | 26 |
03-2028 | 24 |
03-2029 | 24 |
03-2030 | 25 |
Net working capital is expected to increase gradually, with projected changes affecting free cash flow.
Components | Average Days |
---|---|
Days Receivables | 78 |
Days Inventory | 148 |
Days Payables | 54 |
Fiscal Year | EBITDA | Tax | CapEx | Change in NWC | FCF |
---|---|---|---|---|---|
6M/2025 | 45 | 8 | 11 | (2) | 28 |
2026 | 102 | 18 | 22 | 12 | 50 |
2027 | 114 | 20 | 24 | 12 | 58 |
2028 | 121 | 22 | 25 | 4 | 70 |
2029 | 134 | 25 | 27 | 14 | 68 |
Valuation Method | Fair Price (USD) | Potential Upside |
---|---|---|
5-Year DCF (Growth) | 0.00 | -36.5% |
10-Year DCF (Growth) | 0.00 | -28.3% |
5-Year DCF (EBITDA) | 2557.04 | +Inf% |
10-Year DCF (EBITDA) | 2407.56 | +Inf% |
Is Oxford Instruments PLC (OXIG.L) a buy or a sell? Oxford Instruments PLC is definitely a sell. Based on our DCF analysis, Oxford Instruments PLC (OXIG.L) appears to be overvalued with upside potential of -28.3%. The company's strong projected growth in revenue and profitability, coupled with consistent capital expenditure, supports our positive outlook on its intrinsic value.
Key investment drivers include:
Investors should consider reducing exposure at the current market price of $0.00.